Independent Pharmacy & Medical Supply SBA 7(a) buy-vs-build cash-flow calculator
Stress-test building an independent pharmacy & medical supply business from scratch against acquiring an existing cash-flowing resale using SBA 7(a) financing. Adjust startup CapEx, revenue, owner SDE margin, acquisition multiple, and loan terms to compare Year-1 ramp-up cash flow, Debt Service Coverage Ratio (DSCR), and 3-year cumulative owner take-home.
SBA 7(a) underwriting & payback takeaway:
At $4,250,000 revenue and 9% SDE margin ($382,500/yr pre-debt cash flow), buying an existing independent pharmacy & medical supply business at 2.9× SDE ($1,109,250) generates $229,830/yr from Day 1 (2.51× DSCR), giving an immediate $298,647 Year-1 cash-flow advantage over building from scratch during a 14-month ramp-up. Once ramped in Year 2+, building from scratch ($500,000 CapEx) nets $313,683/yr (5.56× DSCR).
Frequently asked questions about starting or buying an independent pharmacy & medical supply business
How much does it cost to start an independent pharmacy & medical supply business?
Starting an independent independent pharmacy & medical supply business typically requires $250,000–$750,000 (State Board of Pharmacy + DEA registration, PBM credentialing, pharmaceutical inventory, and compounding/packaging hood). The largest line-item startup expenses are Opening Prescription & OTC Pharmaceutical Inventory ($100,000–$275,000), Pharmacy Buildout, Narcotics Safe, USP 795/800 Compounding Room & Shelving ($60,000–$210,000), State Board/DEA Licensing, PSAO/PBM Credentialing & Working Capital ($65,000–$190,000). Founders should budget for both initial buildout/equipment CapEx and 9–18 months of working capital runway.
How much do independent pharmacy & medical supply business owners make and what is a healthy profit margin?
Established independent pharmacy & medical supply business operators generate $2,000,000–$6,500,000 in annual gross revenue (45,000–90,000 scripts/year + cash-pay USP 795/797 compounding, immunizations, and DME supplies) with an owner cash flow of 5%–12% SDE margin (Standard PBM insurance scripts have 18%–22% gross margin; compounding, LTC blister-packing, and DME earn 55%–75% gross margins). Key operating ratios include Prescription Drug & Medical Supply COGS: 74%–80% of revenue; Pharmacist-in-Charge (PIC) & Pharmacy Technician Labor: 10%–14% of revenue; Occupancy, Software, Delivery & Insurance: 3%–5% of revenue. Remember that gross revenue is top-line sales before payroll, COGS, and occupancy—not net owner take-home pay.
How is an independent pharmacy & medical supply business valued when buying or selling an existing business?
Operating independent pharmacy & medical supply business resales typically trade at 2.2x–3.5x SDE (plus dollar-for-dollar pharmaceutical inventory) (Clean DEA/Board of Pharmacy licenses with active Medicare/Medicaid/PBM contracts save 9–12 months of startup credentialing), translating to typical acquisition prices of 2.2x–3.5x SDE (plus dollar-for-dollar pharmaceutical inventory) ($200,000–$2,496,000). Key buyer due-diligence priorities: Audit PBM DIR/GER clawback fees and verify what percentage of scripts are underwater on reimbursement. Examine revenue from high-margin niches: Non-sterile/sterile compounding, assisted-living LTC blister packaging, 340B contract pharmacy, or DME.
Is it better to start an independent independent pharmacy & medical supply business or buy a franchise?
An independent independent pharmacy & medical supply business costs $250,000–$750,000 to launch and pays 0% ongoing royalties, whereas comparable franchise systems (Health Mart) require $2,470–$833,870 in disclosed Item 7 opening investment plus Predominantly independent (or low-fee buying groups / Medicine Shoppe / Health Mart). Franchising provides brand playbooks and vendor programs, while independent ownership preserves full margin control and exit flexibility.